|Comvita Limited -- USA Stock|| |
USD 5.99 0.00 0.00%
Mr. Brett Donald Hewlett serves as Independent Director of the Company. He was Chief Executive Officer of the Company., effective October 5, 2015. He is a current member of the New Zealand Trade and Enterprise Better by Design Advisory Board and an Independent Director of the USbased specialty medical device and pharmaceutical company Derma Sciences Inc. Brett holds significant international business development experience, including roles in emerging and developed markets. He previously served 15 years of a 20year career internationally with worldleading food packaging company, Tetra Pak. For five years he served as regional Managing Director of Tetra Paks eastern Mediterranean markets. Prior to that Brett worked as Commercial Director for Tetra Pak in Saudi Arabia and has also held other commercial and project management positions in the UK and Europe. He has run his own strategy consulting company and was an active angel investor supporting startup companies in New Zealand. Brett has a Bachelor of Food Technology degree from Massey University and a Masters of Business Administration from IMD in Switzerland.
Age: 51 CEO Since 2017
64 7 533 1426 http://www.comvita.co.nz
Brett Hewlett Latest Insider Activity
The company has return on total asset (ROA)
of 0.25 %
which means that it generated profit of $0.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 6.64 %
meaning that it generated $6.64 on every $100 dollars invested by stockholders.
The company has accumulated 63.4 M in total debt with debt to equity ratio (D/E) of 46.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Comvita Limited has Current Ratio of 7.87 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Comvita Limited manufactures and markets natural health products. Comvita Limited was founded in 1974 and is headquartered in Te Puke, New Zealand. Comvita Limited operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market.Comvita Limited (CVNZF) is traded on OTC Market in USA. It is located in 23 Wilson Road South and employs 500 people.
Comvita Limited Leadership Team
|Sarah Ottrey, Director|
|Simon Pothecary, Executive|
|Ben Shaw, Executive|
|Paul Reid, Director|
|Roy Ong, Executive|
|Patrick Brus, Executive|
|Alan Bougen, Chairman|
|Maurice Prendergast, Director|
|Scott Coulter, CEO|
|Lucas Bunt, Director|
|Murray Denyer, Director|
|Sharon Hollenstein, Executive|
|Brett Hewlett, CEO|
|Julianne Keast, CFO|
|Mark Sadd, Executive|
|Thomas Cullwick, Director|
|Neil Craig, Chairman|
|Kate Selway, Executive|
|Edward Quilty, Director|
|RalfChristian Schlothauer, Executive|
|MBA DipT, Executive|
|Sarah Kennedy, Director|
|Colin Baskin, Executive|
|Julie Chadwick, Executive|
Stock Performance Indicators
Macroaxis portfolio users are unresponsive in their opinion about investing in Comvita Limited. What is your opinion about investing in Comvita Limited? Are you bullish or bearish?
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1)
For any level of risk, select the one which has the highest expected return. 2)
For any expected return, select the one which has the lowest volatility.